## **Core Concept**
The question assesses knowledge of pharmacological management of overactive bladder (OAB), a condition characterized by urgency, frequency, and urge incontinence. Treatment often involves **antimuscarinics** (also known as anticholinergics) and **beta-3 adrenergic agonists**. Understanding the drug classes and their applications is crucial.

## **Why the Correct Answer is Right**
The correct answer, , is not used for overactive bladder. Typically, drugs used for OAB include:
- **Antimuscarinics** like oxybutynin, tolterodine, and solifenacin, which block muscarinic receptors in the bladder, reducing urgency and urge incontinence.
- **Beta-3 adrenergic agonists** like mirabegron, which relax the bladder muscle by stimulating beta-3 receptors.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is an example of an antimuscarinic used to treat overactive bladder.
- **Option B:** represents another antimuscarinic agent utilized for OAB symptoms.
- **Option D:** could be a beta-3 adrenergic agonist or another class of drug effective in managing OAB.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the management of overactive bladder often involves a careful balance between efficacy and side effects, particularly anticholinergic side effects like dry mouth and constipation. **Solifenacin** is known for having a more favorable side effect profile compared to some other antimuscarinics.

## **Correct Answer:** .